Jeff L Vacirca
CIK 1724161 · last filed 2026-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.15M
Companies
4
Total Filings
30
Lifetime Open-Market Net
$1.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAI | Director | 49,671 | $23.14 | $1.15M | $501.4K | 2 | 2026-05-12 |
| Assertio Holdings, Inc. (ASRT) Delisted | Director | 10,077 | $23.50 | $236.8K | $11.1K | 3 | 2024-06-12 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 0 | $1.03 | $0 | $22.5K | 20 | 2023-08-01 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 23,231 | $1.12 | $26.0K | $574.3K | 5 | 2019-06-28 |
Recent Filings · Page 3 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-28 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +19,231 | $500.0K | EDGAR |
| 2019-06-21 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2019-05-14 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +1,000 | $8.9K | EDGAR |
| 2019-03-19 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +2,000 | $20.9K | EDGAR |
| 2019-03-18 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +2,000 | $19.2K | EDGAR |
| 2019-03-07 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +3,000 | $51.0K | EDGAR |
| 2019-01-03 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-03 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +6,667 | $0 | EDGAR |
| 2018-01-04 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-14 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +1,000 | $23.3K | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.